Centre Hospitalier Universitaire de Montpellier
Centre Hospitalier Universitaire de Montpellier
Montpellier, France11 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects | Ear Diseases, Nausea, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Photophobia, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, brain disorder, central nervous system disorder, eye disorder, headache disorder, hearing disorder, hyperacusis, hypnic headache, migraine disorder, nervous system disorder, otorhinolaryngologic disease, vision disorder | Recruiting | Phase 3 | 2026-09-28 | NCT05156398 | |
| Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 3 | 2026-09-24 | NCT05215340 | |
| A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) | Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy | Active, not recruiting | Phase 3 | 2026-09-22 | NCT06081894 | |
| Two Modalities of Ventilation on the Occurrence of Respiratory Complications During Inhalational Anaesthetic Induction in Children | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Aspiration, respiratory system disorder | Not yet recruiting | Not applicable | 2026-08-17 | NCT07767851 | |
| Phase III Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction | Recruiting | Phase 3 | 2026-08-10 | NCT06745557 | |
| The Pivotal Study of RapidPulseTM Aspiration System | Acute Ischemic Stroke, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-07-02 | NCT06029491 | |
| PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70. | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not applicable | 2026-06-11 | NCT05947136 | |
| Luspatercept in Patients Affected With Rare Inherited Anemias | Hereditary Red Blood Cell Disorder (Disorder) | Not yet recruiting | Phase 2 | 2026-01-12 | NCT07331818 | |
| ALS Phase II Study of NX210c | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Phase 2 | 2025-12-24 | NCT06365216 | |
| Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter | Acute Ischemic Stroke From Large Vessel Occlusion | Recruiting | Not applicable | 2025-12-11 | NCT06370182 | |
| Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer | Resectable Intrahepatic Cholangiocarcinoma | Recruiting | Phase 2 | 2025-08-06 | NCT05265208 |